Ingredient Guide
Vitamin B1 (Thiamine): Benefits, Dosage, and What the Research Says
The original B vitamin - essential for energy, heart muscle, and nerve function, with clinical trial data to back it up.
Written by Jessica Medson
Vitamin B1 (thiamine) is a water-soluble B vitamin that serves as a coenzyme for at least three enzyme complexes central to converting carbohydrates into ATP, and for maintaining normal nerve conduction and heart muscle function. The body stores only about 30 mg at any time, making daily intake critical; plasma thiamine concentrations are reduced by up to 76% in people with type 1 diabetes compared with healthy individuals.<sup><a href="#ref-5">5</a></sup> Clinical research supports thiamine's role in maintaining cardiovascular function in heart failure patients on diuretics, reducing fatigue in people with low thiamine status, and - in its fat-soluble analog form, benfotiamine - showing early signals in cognitive health and nerve symptom management.
What Is Vitamin B1 (Thiamine)?
Vitamin B1, known as thiamine (also spelled thiamin), is a water-soluble B vitamin that the human body cannot synthesize and must obtain continuously through diet or supplementation. It was the first B vitamin to be chemically characterized - hence the designation "B1" - and it remains indispensable to cellular energy metabolism, nerve function, and cardiovascular performance.
Food sources and daily requirements
The richest dietary sources include fortified breakfast cereals (up to 1.2 mg per serving), pork chops, trout, black beans, edamame, and whole grains. Milling white rice or flour removes most of the thiamine originally present, which is why many countries mandate fortification of these staples. The Recommended Dietary Allowance (RDA) for adults is 1.1 mg/day for women and 1.2 mg/day for men, rising to 1.4 mg/day during pregnancy and breastfeeding. Unlike fat-soluble vitamins, the body stores only about 30 mg of thiamine at any given time - primarily in skeletal muscle, heart, liver, kidneys, and brain - so a consistent daily supply matters.
Who faces the greatest deficiency risk?
- People with alcohol dependence: Up to 80% develop thiamine deficiency through poor dietary intake, impaired intestinal absorption, reduced hepatic storage, and liver-related processing issues.
- Older adults: Approximately 20-30% show laboratory indicators of marginal deficiency, often presenting with nonspecific symptoms such as fatigue, reduced appetite, and mild cognitive changes.
- Bariatric surgery patients: Deficiency rates of 16-47% have been documented owing to dietary restriction and reduced intestinal absorption.4
- People with diabetes: Plasma thiamine levels are substantially lower in both type 1 and type 2 diabetes than in healthy individuals, driven by increased renal clearance of the vitamin.5
- People on loop diuretics: Furosemide and similar medications accelerate urinary thiamine loss, an important clinical consideration in heart failure management.1
How Does Thiamine Work in the Body?
The body rapidly converts dietary thiamine into its active coenzyme form, thiamine diphosphate (ThDP), also called thiamine pyrophosphate (TPP). ThDP serves as an essential cofactor for three enzyme complexes that sit at the core of cellular energy production and metabolic regulation:
- Pyruvate dehydrogenase complex (PDC): Converts pyruvate - the end product of glucose breakdown through glycolysis - into acetyl-CoA, which enters the Krebs (citric acid) cycle. Without adequate thiamine, this gateway step slows, forcing cells into less efficient anaerobic metabolism.
- Alpha-ketoglutarate dehydrogenase complex: Drives a critical step within the Krebs cycle, generating NADH used to produce ATP via the mitochondrial electron transport chain. This complex is particularly sensitive to early thiamine depletion in neural tissue.
- Transketolase: Operates in the pentose phosphate pathway, producing nucleotide precursors, supporting NADPH generation, and helping manage cellular oxidative stress. Erythrocyte transketolase activity is commonly used as a clinical marker of thiamine status.
Beyond its coenzyme functions, thiamine participates in nerve signal transmission and helps maintain the myelin sheath - the insulating layer surrounding nerve fibers. These overlapping functions explain why deficiency produces a broad clinical picture spanning metabolic fatigue, peripheral neuropathy, and cognitive disturbance.3 Mechanistic research further suggests that some beneficial effects of thiamine derivatives, particularly benfotiamine, may involve anti-inflammatory and antioxidant pathways operating independently of coenzyme activity.11
Importantly, thiamine requires magnesium for conversion to its active ThDP form, and the two micronutrients are frequently co-depleted in populations at risk of deficiency.4
Thiamine and Energy, Fatigue, and Mental Clarity
Because thiamine anchors multiple enzymatic steps in carbohydrate-to-energy conversion, reduced thiamine status tends to manifest early as fatigue, reduced mental sharpness, and low mood. Several placebo-controlled trials have examined whether supplementation produces measurable benefits in these domains.
What the research shows
A randomized, double-blind crossover clinical trial enrolled 40 adults with fatigue related to quiescent inflammatory bowel disease. Participants received high-dose oral thiamine (600-1800 mg daily, weight-adjusted) or matching placebo for four weeks each, then crossed over. Fatigue scores decreased by a mean of 4.5 points on thiamine versus a 0.75-point increase on placebo (p = 0.0003). Between 55% and 75% of participants achieved a clinically meaningful improvement (at least 3 points) while taking thiamine, compared with only 25-35% on placebo.14
An earlier double-blind, placebo-controlled trial administered 50 mg thiamine daily for two months to 120 young adult women whose baseline thiamine levels were already within conventionally normal limits. Those who showed the greatest improvement in thiamine status reported feeling more clearheaded, composed, and energetic, and demonstrated faster reaction times compared with the placebo group - effects that emerged even without pre-existing deficiency.12
In an older population, a six-week trial in elderly Irish women with marginal thiamine deficiency found that 10 mg thiamine daily significantly increased energy intake, appetite, body weight, and overall sense of well-being, while reducing fatigue and daytime sleepiness, compared with placebo.13
Taken together, these findings suggest thiamine supplementation supports energy levels and mental vitality, particularly in people whose dietary intake is marginal. Whether pharmacological doses benefit individuals with genuinely adequate thiamine status remains less established and requires further investigation.
Thiamine and Cardiovascular Support
Heart muscle cells require continuous, high-volume ATP production and are among the first tissues to suffer when thiamine is depleted. In severe deficiency, "wet beriberi" manifests as high-output heart failure, peripheral edema, and dilated cardiomyopathy. A more subtle but clinically common concern in modern medicine involves long-term diuretic use: loop diuretics such as furosemide increase urinary thiamine excretion, potentially driving subclinical depletion in people already vulnerable to cardiac compromise.
What the research shows
A systematic review and meta-analysis pooled data from two randomized, double-blind, placebo-controlled trials in patients with systolic heart failure. Thiamine supplementation produced a statistically significant net improvement in left ventricular ejection fraction (LVEF) of 3.28% (95% CI: 0.64%, 5.93%) compared with placebo - a clinically relevant gain given that small LVEF changes correlate meaningfully with functional outcomes in this population.1
One of the trials contributing to this analysis enrolled 30 patients with congestive heart failure receiving chronic furosemide therapy (80-240 mg/day for 3-14 months). Following intravenous thiamine repletion, LVEF rose from 0.28 to 0.32, representing approximately a 22% relative improvement (p < 0.05), and diuresis improved significantly as well.2
These findings are based on a small combined sample (n = 38) and longer-duration trials with larger cohorts are needed before thiamine supplementation can be broadly recommended for heart failure management. However, they highlight a straightforward clinical consideration: people with heart failure on furosemide may have unrecognized thiamine depletion, and supplementation carries a favorable risk profile.
Thiamine, Nerve Health, and Blood Glucose Regulation
Thiamine has two interconnected roles relevant to diabetes and nerve health: its function in glucose metabolism pathways, and its direct involvement in myelin maintenance and nerve conduction. Both intersect in ways that make thiamine status particularly relevant for people managing blood sugar over the long term.
Thiamine status in diabetes
A large observational study found that plasma thiamine concentrations were 76% lower in people with type 1 diabetes compared with healthy controls - and similarly reduced in type 2 diabetes - driven by a 24-fold increase in renal thiamine clearance in type 1 and a 16-fold increase in type 2 diabetes.5 Laboratory research suggests this depletion may impair transketolase activity, allowing harmful glucose metabolites to accumulate in vascular and nerve tissue and potentially contributing to diabetic complications over time.6
Benfotiamine and neuropathy - what the research shows
Benfotiamine is a fat-soluble synthetic derivative of thiamine that achieves higher intracellular thiamine diphosphate concentrations than standard oral thiamine. It has been the focus of most clinical research on thiamine for diabetic peripheral neuropathy:
- The BEDIP pilot RCT (n = 40, three weeks) found statistically significant improvement in neuropathy scores (p = 0.0287) and pain reduction (p = 0.0414) with benfotiamine 400 mg/day versus placebo, with no adverse effects attributable to treatment.7
- The BENDIP RCT (n = 165, six weeks) demonstrated that the higher benfotiamine dose (600 mg/day) produced greater improvement in the Neuropathy Symptom Score than the lower dose (300 mg/day), with pain relief the most prominent benefit, and both doses were well tolerated.8
However, the more recent BOND trial (n = 57, 12 months, benfotiamine 600 mg/day) - the longest controlled study to date - found no statistically significant differences between benfotiamine and placebo on corneal nerve fiber density, skin biopsy measures, nerve conduction studies, or most clinical outcomes. A trend in Neuropathy Symptom Score (p = 0.098) did not reach significance.9 The evidence for benfotiamine in diabetic neuropathy is therefore mixed: short-term symptom signals have not been confirmed over 12 months, and longer or larger trials are needed before firm conclusions can be drawn.
Cognitive health - what the research shows
A Phase IIa randomized, double-blind, placebo-controlled trial in adults with mild cognitive impairment or mild Alzheimer's disease found that 12 months of oral benfotiamine reduced worsening of the Clinical Dementia Rating (CDR) by 77% compared with placebo (p = 0.034). ADAS-Cog decline was 43% lower in the benfotiamine group, though this difference did not reach statistical significance (p = 0.125). Benfotiamine also significantly reduced circulating advanced glycation end products (AGEs) and improved brain glucose metabolism by FDG-PET at one year.10 These are encouraging early signals from a small pilot trial; a larger Phase IIB study is ongoing. Mechanistic reviews suggest that thiamine derivatives may exert anti-inflammatory and antioxidant effects through pathways independent of their coenzyme functions, potentially explaining neuroprotective signals in these studies.11
Safety, Side Effects, and Drug Interactions
Thiamine has an excellent safety record. The Food and Nutrition Board has not established an upper tolerable intake level (UL) because no adverse effects from high oral thiamine intake have been consistently documented in the scientific literature. Clinical trials administering hundreds of milligrams per day over weeks to months have reported good tolerability with minimal side effects.
Drug and substance interactions
- Furosemide and loop diuretics: Long-term furosemide use is linked to clinically meaningful reductions in blood thiamine concentrations through accelerated urinary excretion. In people with heart failure on chronic furosemide, this can contribute to further impairment of cardiac function - an interaction with direct therapeutic implications.12 Discussing thiamine status with a cardiologist or prescribing clinician is advisable for anyone on long-term loop diuretic therapy.
- Fluorouracil (5-FU): This chemotherapy agent has been associated with thiamine depletion. Case reports describe beriberi and Wernicke's encephalopathy in patients receiving prolonged 5-FU infusions. Oncology teams should be aware of this potential interaction in nutritionally vulnerable patients.
- Alcohol: Chronic alcohol use impairs thiamine absorption from the gut, reduces hepatic storage, and interferes with conversion to the active ThDP form. Thiamine repletion is standard supportive care in alcohol-related medical presentations. The optimal dosing regimen for symptomatic Wernicke encephalopathy remains an active area of research; one well-powered RCT found no clear neurological benefit of high-dose over lower-dose thiamine in this setting.15
Pregnancy and breastfeeding
The RDA increases to 1.4 mg/day during both pregnancy and lactation. Severe maternal thiamine deficiency during breastfeeding can cause infantile beriberi, which carries significant infant mortality risk in areas where deficiency is prevalent.3 At typical supplemental doses, thiamine is not known to pose risk during pregnancy, but individuals with high-risk pregnancies or complex nutritional situations should discuss all supplementation with their obstetric care team.
Rare hypersensitivity
Allergic reactions to thiamine are rare and primarily documented with intravenous or intramuscular administration at high doses, not with oral supplementation. Standard oral thiamine supplements have not been associated with clinically significant allergic reactions in the published literature.
If you take prescription diuretics, diabetes medications, chemotherapy agents, or are pregnant, consult a qualified healthcare provider before starting any thiamine or benfotiamine supplement.
Thiamine Dosage Reference
Doses below are drawn from cited clinical research and established dietary guidelines. Individual needs vary; consult a healthcare provider before supplementing at pharmacological doses.
| Goal | Typical Dose | Timing | Notes |
|---|---|---|---|
| General adult health (RDA) | 1.1 mg/day (women) / 1.2 mg/day (men) | With or without food | Achievable through a balanced diet; standard multivitamin typically covers this. No UL established. |
| Pregnancy and breastfeeding | 1.4 mg/day | Daily, consistent timing | Increased demand; most prenatal vitamins provide adequate thiamine. |
| Fatigue in IBD (research dose) | 600-1800 mg/day (weight-based) | Divided doses with food | Used in the Bager et al. 2021 RCT; high-dose pharmacological use - physician oversight recommended. |
| Mood and cognitive support (research dose) | 50 mg/day | Once daily with food | Dose used in the Benton et al. 1997 RCT in young adult women; well above the RDA but generally well tolerated. |
| Cardiovascular support (research dose) | 100-300 mg/day | Daily with food | Range used in heart failure trials; consider under medical supervision given the underlying condition. |
| Diabetic neuropathy - benfotiamine (research dose) | 300-600 mg/day | Divided doses with meals | Used in BEDIP/BENDIP RCTs; higher dose (600 mg) showed more consistent signal. Note: BOND trial showed no effect at 12 months. |
| Cognitive health - benfotiamine (research dose) | 600 mg/day (300 mg twice daily) | With meals | Used in the Gibson et al. 2020 Phase IIa Alzheimer's RCT; data are preliminary. |
Benfotiamine is a fat-soluble thiamine analog studied in specific clinical contexts; it is not interchangeable with standard thiamine supplements. RDA = Recommended Dietary Allowance set by the Food and Nutrition Board.
Vitamin B1 (Thiamine): What the Evidence Shows at a Glance
Summary of the strongest available clinical evidence by outcome area. Tier A = human RCT or meta-analysis; Tier B = human observational study; Tier C = animal or cell data only.
| Outcome area | Key finding from research | Evidence strength |
|---|---|---|
| Energy and fatigue | High-dose thiamine reduced fatigue scores by 4.5 pts vs. +0.75 on placebo in an IBD crossover RCT (p = 0.0003) | Tier A - RCT |
| Mood and mental clarity | 50 mg/day for 2 months: participants felt more clearheaded, energetic, with faster reaction times vs. placebo - even with normal baseline levels | Tier A - RCT |
| General well-being (older adults) | 10 mg/day for 6 weeks in elderly women with marginal deficiency: significantly improved appetite, energy, and well-being vs. placebo | Tier A - RCT |
| Cardiovascular function (heart failure) | Meta-analysis of 2 RCTs: LVEF improved net 3.28% (95% CI 0.64-5.93%) vs. placebo in systolic heart failure on furosemide | Tier A - Meta-analysis |
| Diabetic peripheral neuropathy (benfotiamine) | Short-term RCTs (BEDIP, BENDIP) showed improved symptom scores; 12-month BOND trial found no significant structural or functional benefit | Tier A - mixed results |
| Cognitive decline (benfotiamine) | Phase IIa RCT: CDR worsening 77% lower (p = 0.034); ADAS-Cog 43% lower (p = 0.125, not significant) - preliminary data | Tier A - early signal, needs replication |
| Thiamine blood levels in diabetes | Plasma thiamine 76% lower in type 1 diabetes vs. healthy controls; 24-fold increased renal clearance | Tier B - observational |
Benfotiamine is a fat-soluble thiamine analog; its clinical evidence base differs from standard oral thiamine. NS = not statistically significant.
Frequently Asked Questions
What is Vitamin B1 (Thiamine) good for?
Thiamine supports energy production, heart muscle function, nerve health, and mental clarity. Its active form - thiamine diphosphate - serves as a coenzyme for at least three enzymes that convert carbohydrates into ATP. Clinical research suggests it helps maintain cardiovascular function in heart failure patients on diuretics and may support fatigue management, particularly in people with marginal thiamine status.
How much Vitamin B1 (Thiamine) should I take per day?
The Recommended Dietary Allowance is 1.1 mg/day for adult women and 1.2 mg/day for men, rising to 1.4 mg during pregnancy and breastfeeding. Clinical trials have used far higher doses - 50 mg for mood studies and 600-1800 mg for fatigue research. No upper intake limit has been established, but pharmacological doses should be used under medical guidance.
What foods are highest in Vitamin B1 (Thiamine)?
The richest sources include fortified breakfast cereals (up to 1.2 mg per serving), pork chops, trout, black beans, and edamame. Whole grains, legumes, and sunflower seeds also contribute meaningful amounts. Milling removes most of the thiamine from white rice and refined flour, which is why many countries mandate fortification of these staples.
Who is most at risk for Vitamin B1 (Thiamine) deficiency?
People with alcohol dependence face the highest risk - up to 80% develop deficiency through poor intake, impaired absorption, and liver-related processing problems. Other high-risk groups include bariatric surgery patients (deficiency rates of 16-47%), older adults, people with type 1 or type 2 diabetes (plasma levels up to 76% lower than controls), and individuals on long-term furosemide therapy.
Can Vitamin B1 (Thiamine) help with fatigue?
Research suggests it may, particularly for people with marginal or depleted thiamine status. A randomized crossover trial in adults with fatigue related to inflammatory bowel disease found high-dose thiamine reduced fatigue scores significantly more than placebo (p = 0.0003), with 55-75% of participants showing meaningful improvement on thiamine versus 25-35% on placebo. Effects in fully nourished individuals without deficiency are less established.
Is Vitamin B1 (Thiamine) safe to take?
Oral thiamine supplements are among the safest micronutrients available. The Food and Nutrition Board has not set an upper tolerable intake level because high-dose oral supplementation has not produced adverse effects in human studies. Clinical trials administering hundreds of milligrams daily for months have reported good tolerability. Rare allergic reactions are primarily associated with intravenous administration, not oral use.
What happens if you don't get enough Vitamin B1 (Thiamine)?
Mild shortfall typically causes fatigue, irritability, and difficulty concentrating. More severe deficiency causes beriberi - either 'dry beriberi' with peripheral neuropathy and muscle weakness, or 'wet beriberi' with high-output heart failure and edema. Critically severe deficiency can cause Wernicke encephalopathy, an acute neurological emergency marked by confusion, abnormal eye movements, and gait instability requiring immediate medical treatment.
Does Vitamin B1 (Thiamine) interact with any medications?
Yes. Long-term furosemide (a loop diuretic) use reduces blood thiamine levels through urinary loss - an important concern in heart failure patients. The chemotherapy drug fluorouracil (5-FU) has been associated with thiamine depletion and rare cases of beriberi. Chronic alcohol use significantly impairs thiamine absorption and utilization. Always inform your healthcare provider and pharmacist about all supplements.
Is benfotiamine the same as regular Vitamin B1 (Thiamine)?
They are related but not identical. Benfotiamine is a fat-soluble synthetic analog of thiamine that achieves higher intracellular thiamine diphosphate concentrations after oral dosing than standard water-soluble thiamine. It has been studied separately for diabetic neuropathy and cognitive health. Short-term trials showed some symptom benefit for nerve pain, but a 12-month placebo-controlled trial found no significant structural or functional neuropathy benefit.
Can Vitamin B1 (Thiamine) support heart health?
Research suggests it may support cardiac function specifically in people with heart failure who are taking furosemide. A meta-analysis of two randomized controlled trials found thiamine improved left ventricular ejection fraction by 3.28% compared with placebo (95% CI: 0.64-5.93%). This finding is based on a small combined sample (n = 38) and is promising rather than definitive - discuss it with your cardiologist before supplementing.
Shop Vitamin B1 (Thiamine)
HealthFare Vitamin B1 (Thiamine) supplements
Scientific References
- 1.DiNicolantonio JJ, Lavie CJ, Niazi AK, O'Keefe JH, Hu T Effects of thiamine on cardiac function in patients with systolic heart failure: systematic review and metaanalysis of randomized, double-blind, placebo-controlled trials. Ochsner Journal. 2013. PubMed: 24357996Clinical (RCT / meta-analysis)
- 2.Shimon I, Almog S, Vered Z, Seligmann H, Shefi M, Peleg E, Rosenthal T, Motro M, Halkin H, Ezra D Improved left ventricular function after thiamine supplementation in patients with congestive heart failure receiving long-term furosemide therapy. American Journal of Medicine. 1995. PubMed: 7733128Clinical (RCT / meta-analysis)
- 3.Whitfield KC, Bourassa MW, Adamolekun B, et al. Thiamine deficiency disorders: diagnosis, prevalence, and a roadmap for global control programs. Annals of the New York Academy of Sciences. 2018. PubMed: 30151974Human observational
- 4.Maguire D, Talwar D, Shiels PG, McMillan D The role of thiamine dependent enzymes in obesity and obesity related chronic disease states: A systematic review. Clinical Nutrition ESPEN. 2018. PubMed: 29779823Human observational
- 5.Thornalley PJ, Babaei-Jadidi R, Al Ali H, Rabbani N, Antonysunil A, Larkin J, Ahmed A, Rayman G, Bodmer CW High prevalence of low plasma thiamine concentration in diabetes linked to a marker of vascular disease. Diabetologia. 2007. PubMed: 17676306Human observational
- 6.Beltramo E, Berrone E, Tarallo S, Porta M Effects of thiamine and benfotiamine on intracellular glucose metabolism and relevance in the prevention of diabetic complications. Acta Diabetologica. 2008. PubMed: 18581039Preclinical (animal / cell)
- 7.Haupt E, Ledermann H, Kopcke W Benfotiamine in the treatment of diabetic polyneuropathy - a three-week randomized, controlled pilot study (BEDIP study). International Journal of Clinical Pharmacology and Therapeutics. 2005. PubMed: 15726875Clinical (RCT / meta-analysis)
- 8.Stracke H, Gaus W, Achenbach U, Federlin K, Bretzel RG Benfotiamine in diabetic polyneuropathy (BENDIP): results of a randomised, double blind, placebo-controlled clinical study. Experimental and Clinical Endocrinology and Diabetes. 2008. PubMed: 18473286Clinical (RCT / meta-analysis)
- 9.Ziegler D, Sipola G, Strom A, Strassburger K, et al. Effects of benfotiamine treatment over 12 months on morphometric, neurophysiological and clinical measures in type 2 diabetes patients with symptomatic polyneuropathy: a randomized, placebo-controlled, double-blind clinical trial (BOND study). BMJ Open Diabetes Research and Care. 2026. PubMed: 41571333Clinical (RCT / meta-analysis)
- 10.Gibson GE, Luchsinger JA, Cirio R, Chen H, Franchino-Elder J, Hirsch JA, et al. Benfotiamine and Cognitive Decline in Alzheimer's Disease: Results of a Randomized Placebo-Controlled Phase IIa Clinical Trial. Journal of Alzheimer's Disease. 2020. PubMed: 33074237Clinical (RCT / meta-analysis)
- 11.Sambon M, Wins P, Bettendorff L Neuroprotective Effects of Thiamine and Precursors with Higher Bioavailability: Focus on Benfotiamine and Dibenzoylthiamine. International Journal of Molecular Sciences. 2021. PubMed: 34063830Preclinical (animal / cell)
- 12.Benton D, Griffiths R, Haller J Thiamine supplementation mood and cognitive functioning. Psychopharmacology. 1997. PubMed: 9122365Clinical (RCT / meta-analysis)
- 13.Smidt LJ, Cremin FM, Grivetti LE, Clifford AJ Influence of thiamin supplementation on the health and general well-being of an elderly Irish population with marginal thiamin deficiency. Journal of Gerontology. 1991. PubMed: 1986037Clinical (RCT / meta-analysis)
- 14.Bager P, Hvas CL, Rud CL, Dahlerup JF Randomised clinical trial: high-dose oral thiamine versus placebo for chronic fatigue in patients with quiescent inflammatory bowel disease. Alimentary Pharmacology and Therapeutics. 2021. PubMed: 33210299Clinical (RCT / meta-analysis)
- 15.Dingwall KM, Delima JF, Binks P, Batey R, Bowden SC What is the optimum thiamine dose to treat or prevent Wernicke's encephalopathy or Wernicke-Korsakoff syndrome? Results of a randomized controlled trial. Alcoholism: Clinical and Experimental Research. 2022. PubMed: 35428992Clinical (RCT / meta-analysis)